Limitations of urinary telomerase activity measurement in urothelial cancer

被引:17
作者
Arai, Y
Yajima, T
Yagihashi, A
Kobayashi, D
Kameshima, H
Sasaki, M
Tanaka, K
Kuwajima, K
Miyao, N
Tsukamoto, T
Watanabe, N [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Lab Diagnosis, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan
关键词
telomerase activity; exfoliated cells; voided urine; urothelial cancer;
D O I
10.1016/S0009-8981(00)00202-3
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The reported frequency of detectable telomerase activity in spontaneously voided urine samples from patients with urothelial cancer varied from 0 to 85%. We examined stasis in the bladder and specimen storage as interfering conditions in this assay. Telomerase activity in exfoliated cells was measured by a polymerase-chain-reaction-based assay in spontaneously voided urine from urothelial cancer patients. Effects of retention in the bladder and specimen storage from voiding to measurement of telomerase activity were modeled by suspending 10 degrees cells from the cancer-derived T24 line in normal urine (pH 6.5) at 37 degrees C and 25 degrees C, respectively. Hematuria was modeled by adding hemoglobin. In T24 cells suspended in urine at 37 degrees C, telomerase activity had decreased to approximately 20% of preincubation activity after 1 h, and had disappeared after 3 h. In urine at 25 degrees C, telomerase activity in T24 cells had decreased to approximately 40% of preincubation activity at 1 h and to < 10% at 6 h. When we examined telomerase activity in exfoliated cells in spontaneously voided urine from urothelial cancer patients (excluding first-voided morning specimens), telomerase activity was detected in only 21% of samples (four of 19) despite measurement with 1 h of voiding and steps to avoid hemoglobin interference, Measurement of telomerase activity in spontaneously voided urine is insufficiently sensitive and reliable for the diagnosis of urothelial cancer. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 22 条
[1]  
CHADENEAU C, 1995, CANCER RES, V55, P2533
[2]  
Dalbagni G, 1997, CLIN CANCER RES, V3, P1593
[3]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[4]  
Heine B, 1998, J PATHOL, V184, P71
[5]   Telomerase activity in human breast tumors [J].
Hiyama, E ;
Gollahon, L ;
Kataoka, T ;
Kuroi, K ;
Yokoyama, T ;
Gazdar, AF ;
Hiyama, K ;
Piatyszek, MA ;
Shay, JW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (02) :116-122
[6]  
HIYAMA E, 1995, CANCER RES, V55, P3258
[7]  
Ito H, 1998, CLIN CANCER RES, V4, P2807
[8]  
Kavaler E, 1998, CANCER, V82, P708, DOI 10.1002/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO
[9]  
2-1
[10]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015